TG Therapeutics (NASDAQ:TGTX) Stock, Earnings Estimates, EPS, And Revenue

TG Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 26
EPS Estimate
$0.080
Quarterly Revenue Estimate
$99.36M
Annual Revenue
(as of Sep 30)
$264.79M

Analyze the earnings history of TG Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

TG Therapeutics (TGTX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-04$0.02$0.03-33.3 %
Q22024-08-06$0.04$-0.05180.0 %
Q12024-05-01$-0.07$-0.04-75.0 %
Q42024-02-28$-0.09$-0.1010.0 %

TG Therapeutics (TGTX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-04$83.88M$81.71M2.65 %
Q22024-08-06$73.47M$65.89M11.5 %
Q12024-05-01$63.47M$54.58M16.3 %
Q42024-02-28$43.97M$40.06M9.76 %

FAQ

Q

When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?

A

TG Therapeutics (TGTX) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for TG Therapeutics (NASDAQ:TGTX)?

A

The Actual EPS was $0.02, which missed the estimate of $0.03.

Q

What were TG Therapeutics’s (NASDAQ:TGTX) revenues?

A

The Actual Revenue was $83.9M, which beat the estimate of $81.7M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch